The Quarterly Rate Reset — October 2026 payment limits

Sent Sep 20, 2026 · 800 payment limits moved · 38 new codes · 10 retired. This is the issue exactly as subscribers received it.

The Quarterly Rate Reset

CMS released the October 2026 Part B payment-limit file. Here's what changed: 800 payment limits moved, 38 codes are new, and 10 were retired.

Source: the CMS quarterly ASP pricing file (cms.gov ASP pricing files). Payment limit = ASP + 6%. Codes we cover link straight to their billing reference; the rest link to the full by-code index.

New codes this quarter

Billable as of the file's effective date — the first quarter a code appears is when practices lose money to "not yet in the charge master."

Retired codes

Claims using a retired code after its end date will deny. Check your charge master.

Re-quote these first

The limits that moved most among drugs with real dollars attached. Patients scheduled after the effective date owe 20% of the new number, not the old one.

Code Payment limit Change
J9304
Inj. pemetrexed, 10 mg
$7.99 → $92.50
per 10 MG
▲ 1057.2%
J3489
Zoledronic acid 1mg
$3.36 → $17.67
per 1 MG
▲ 425.8%
Q5120
Inj pegfilgrastim-bmez 0.5mg
$132.10 → $302.25
per 0.5 MG
▲ 128.8%
Q5119
Inj ruxience, 10 mg
$16.16 → $5.79
per 10 MG
▼ 64.2%
Q5112
Inj ontruzant 10 mg
$20.99 → $32.79
per 10 MG
▲ 56.2%
J2175
Meperidine hydrochl /100 mg
$6.34 → $9.65
per 100 MG
▲ 52.3%
J2562
Plerixafor injection
$28.49 → $42.94
per 1 MG
▲ 50.7%
J2778
Ranibizumab injection
$51.09 → $26.38
per 0.1 mg
▼ 48.4%

Your reload checklist

Re-check units and wastage

Want the new numbers as patient estimates? CareCost re-quotes a patient in about 90 seconds — free to try.

Erin Rose, CareCost
Reply to this email and it reaches me, not a ticket queue.

Compiled from the CMS October 2026 ASP pricing file (payment limit = ASP + 6%), compared against the prior quarter (2026 Q3).